New daily pill shows promise for weight loss in early trial
Disease control
Completed
This study tested an experimental daily pill called TERN-601 for weight loss in 167 adults with overweight or obesity. Participants took the pill or a placebo for 12 weeks to see how much weight they lost and if it was safe. The goal is to find a convenient oral treatment to help…
Phase: PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated May 06, 2026 16:01 UTC